AstraZeneca (AZN)
Share price graph
Contact details
Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Website: www.astrazeneca.com
Company information
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.
Related news from City A.M.
Strong growth in Chinese demand for new medicines helped Astrazeneca return to growth in 2018, it said today. [...]
The trade body for UK investment managers has written to 32 companies on the Ftse-all share to register concern [...]
The FTSE 100 lost ground today, down 5.31 points at 7,032.70 just before markets closed after a turbulent start [...]
Shares in Astrazeneca dipped after the pharmaceutical giant revealed it had not reached the results it had hoped [...]
Back in July 2016, Theresa May launched her campaign for leadership of the Conservative party by promising radical [...]
The boards at several big-name companies will face a barrage of investor questions this week, as shareholders [...]
British Gas owner Centrica said in a trading update today that its services division had been under pressure due [...]
Major UK firms have told ministers of their fears that Brexit could leave them facing a shortfall of workers. [...]
Those looking for an income from the stock market often turn to Equity Income funds. They provide a portfolio [...]
Astrazeneca has hailed the success of its new Type 2 diabetes drugs, after a study of more than 300,000 people [...]
Shares in Neil Woodford-backed pharmaceuticals firm Circassia rocketed over 30 per cent this morning after [...]
Pharmaceuticals giant AstraZeneca has turned to an innovative startup helping patients, doctors and researchers [...]
AstraZeneca has struck a $320m (£256m) deal with TerSera Therapeutics to sell the commercial rights of its [...]
AstraZeneca shares slipped over one per cent after warning many of its patents will run out during 2017. [...]
AstraZeneca is forecast to report disappointing results this week as competition continues to drag on sales. [...]
Content tagged with "AstraZeneca"